Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15 , 722. - Yalçın, Nazif; Aktaş, Selman; Uyar, Seyit; Koca, Nizameddin (Life (2075-1729), 2026)